Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed Mitwalli

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 11, 2022
Benjamin M Clanner-Engelshofen, Leonie Frommherz, Mohammed Mitwalli, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 21, 2022
3D printing and silicone models of primary skin lesions for dermatological education as remote learning toolBenjamin M Clanner-Engelshofen, Leonie Frommherz, Mohammed Mitwalli, et al.
Journal for Immunotherapy of Cancer|June 12, 2026
Extracorporeal photopheresis versus systemic immunosuppression for treatment of immune-related adverse events: clinical outcomes from the prospective two-arm PRIA studyLisa Wein, Carolin Ertl, Theresa Ruf, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 11, 2022
Benjamin M Clanner-Engelshofen, Leonie Frommherz, Mohammed Mitwalli, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 21, 2022
3D printing and silicone models of primary skin lesions for dermatological education as remote learning toolBenjamin M Clanner-Engelshofen, Leonie Frommherz, Mohammed Mitwalli, et al.
Journal for Immunotherapy of Cancer|June 12, 2026
Extracorporeal photopheresis versus systemic immunosuppression for treatment of immune-related adverse events: clinical outcomes from the prospective two-arm PRIA studyLisa Wein, Carolin Ertl, Theresa Ruf, et al.
Pageof 1